You are here Ask an Expert

Yot Teerawattananon

Senior Researcher

Thailand
Health Intervention and Technology Assessment Program (HITAP)

Biography

Dr. Yot Teerawattananon is a founding leader of the Health Intervention and Technology Assessment Program (HITAP), which is a semi-autonomous research institute of Thailand’s Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines, medical devices, health promotion and disease prevention programmes under the Universal Health Coverage Scheme and the national pharmaceutical reimbursement list, the National List of Essential Medicines.


Yot has gone on to provide technical advice to many national and international agencies such as: the Gates Foundation, WHO, World Bank, Asian Development Bank and the Centre for Global Development (CGD), giving him a broad knowledge of key issues in global health. He is also one of the founders of HTAsiaLink, a regional networks comprising of governmental health technology assessment agencies in South Korea, Japan, China, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Bhutan and Thailand.


Learn more about him!

CV_Dr Yot Teerawattananon

7 Answers
7 related questions found.

CEA studies may be prospective studies or modelled studies

CEA studies may be prospective studies or modelled studies. Would economic evaluations be called “modelled studies” (clinical outcome is taken from systematic review and meta-analysis) rather than collecting primary data to measure clinical outcomes? If data for clinical outcome is collected, sh...

Asked: 27 Feb 2017  |   322 views  |   1 answer

Can discount rates use the country’s inflation rates, instead of using rates such as 3-6%, as indicated in some guidelines?

Can discount rates use the country’s inflation rates, instead of using rates such as 3-6%, as indicated in some guidelines?

Asked: 27 Feb 2017  |   326 views  |   1 answer

If a hospital would like to undertake a study on economic evaluation, what threshold should the hospital use? Since threshold is applied on a national level, can the hospital simply use ACER instead of ICER? Many

If a hospital would like to undertake a study on economic evaluation, what threshold should the hospital use? Since threshold is applied on a national level, can the hospital simply use ACER instead of ICER? Many

Asked: 27 Feb 2017  |   271 views  |   1 answer

Why should countries consider using MCDA, in addition to economic evaluations?

Why should countries consider using MCDA, in addition to economic evaluations?

Asked: 27 Feb 2017  |   255 views  |   2 answers

How to prevent drug companies to mess with my economic evaluation study??

How to prevent drug companies to mess with my economic evaluation study?

Asked: 08 Mar 2017  |   286 views  |   2 answers

QALY

What is a QALY?

Asked: 09 May 2017  |   177 views  |   1 answer

Expected Value of Perfect Information

How useful really is Expected Value of Perfect Information as an additional analysis to support decision-making for the healthcare system? Are there settings/countries now who are conducting this as part of their standard analysis to complement the results of cost effectiveness analysis?

Asked: 30 May 2018  |   36 views  |   2 answers